405 related articles for article (PubMed ID: 23800326)
1. From modeling to morals: imagining the future of HIV PREP in Lesotho.
Kenworthy NJ; Bulled N
Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326
[TBL] [Abstract][Full Text] [Related]
2. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
Haire B; Kaldor JM
Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
[TBL] [Abstract][Full Text] [Related]
3. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
Rennie S
Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
[TBL] [Abstract][Full Text] [Related]
4. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
[TBL] [Abstract][Full Text] [Related]
5. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.
Burns DN; Grossman C; Turpin J; Elharrar V; Veronese F
Curr HIV/AIDS Rep; 2014 Dec; 11(4):393-403. PubMed ID: 25283184
[TBL] [Abstract][Full Text] [Related]
6. Ethical challenges of preexposure prophylaxis for HIV.
Jay JS; Gostin LO
JAMA; 2012 Sep; 308(9):867-8. PubMed ID: 22847147
[No Abstract] [Full Text] [Related]
7. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
[TBL] [Abstract][Full Text] [Related]
8. Separate goals, converging priorities: on the ethics of treatment as prevention.
Ostmann F; Saenz C
Dev World Bioeth; 2013 Aug; 13(2):57-62. PubMed ID: 23800304
[TBL] [Abstract][Full Text] [Related]
9. Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa.
Naicker CL; Mansoor LE; Dawood H; Naidoo K; Singo D; Matten D; Williamson C; Abdool Karim Q
BMC Infect Dis; 2020 Jul; 20(1):532. PubMed ID: 32698772
[TBL] [Abstract][Full Text] [Related]
10. I Am Men's Health: Generating Adherence to HIV Pre-Exposure Prophylaxis (PrEP) in Young Men of Color Who Have Sex with Men.
Daughtridge GW; Conyngham SC; Ramirez N; Koenig HC
J Int Assoc Provid AIDS Care; 2015; 14(2):103-7. PubMed ID: 25331226
[TBL] [Abstract][Full Text] [Related]
11. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
Verguet S; Stalcup M; Walsh JA
Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
[TBL] [Abstract][Full Text] [Related]
12. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
[TBL] [Abstract][Full Text] [Related]
13. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
Van der Elst EM; Mbogua J; Operario D; Mutua G; Kuo C; Mugo P; Kanungi J; Singh S; Haberer J; Priddy F; Sanders EJ
AIDS Behav; 2013 Jul; 17(6):2162-72. PubMed ID: 23080358
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
[TBL] [Abstract][Full Text] [Related]
15. How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".
Calabrese SK; Underhill K
Am J Public Health; 2015 Oct; 105(10):1960-4. PubMed ID: 26270298
[TBL] [Abstract][Full Text] [Related]
16. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
McMahon JM; Myers JE; Kurth AE; Cohen SE; Mannheimer SB; Simmons J; Pouget ER; Trabold N; Haberer JE
AIDS Patient Care STDS; 2014 Sep; 28(9):462-74. PubMed ID: 25045996
[TBL] [Abstract][Full Text] [Related]
17. Pre-exposure prophylaxis for conception (PrEP-C) as a risk reduction strategy in HIV-positive men and HIV-negative women in the UK.
Whetham J; Taylor S; Charlwood L; Keith T; Howell R; McInnes C; Payne E; Home J; White D; Gilleece Y
AIDS Care; 2014; 26(3):332-6. PubMed ID: 23876052
[TBL] [Abstract][Full Text] [Related]
18. How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention.
Haire B; Kaldor J; Jordens CF
Am J Bioeth; 2012; 12(6):21-30. PubMed ID: 22650457
[TBL] [Abstract][Full Text] [Related]
19. Are we prepped for preexposure prophylaxis (PrEP)? Provider opinions on the real-world use of PrEP in the United States and Canada.
Karris MY; Beekmann SE; Mehta SR; Anderson CM; Polgreen PM
Clin Infect Dis; 2014 Mar; 58(5):704-12. PubMed ID: 24319083
[TBL] [Abstract][Full Text] [Related]
20. A perspective on progress and gaps in HIV prevention science.
Kiser PF; Mesquita PM; Herold BC
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1373-8. PubMed ID: 22966871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
